boris johnson semaglutide To fight new COVID strain, UK PM reverses Christmas plans for millions Boris Johnson uses first Daily

Constipation affected 22% to 25%

Average Weight Loss with GLP-1 Medications Clinical studies and real-world data show that patients using GLP-1 medications experience substantial weight loss: Semaglutide : Patients typically lose 15% of their body weight over 1218 months when paired with a balanced diet and regular exercise

Indeed, plasma cyclin-dependent kinase levels strongly correlated with homocysteine in homocystinuric patients (Fritzer-Szekeres et al, 1998)

The most common gastrointestinal side effects include nausea (up to 44%), diarrhoea (30%), vomiting (24%), constipation (24%), and abdominal pain (20%)

Drug Delivery Translational Research 9, 625630